high estorgen on 180 mgs enanthate

maxxmill17

New member
i get joint pain from all anti e's could clomid be of any help to me while doing trt? thx

i do approx 85 mgs test on sunday and thursday.. blood work t level about 1000 e about 80
 
Last edited:
You might also be an Aromatase inhibitor (AI) over-responder (Term from another board I frequent). I'd stick with adex or aromasin and just lower the dosage. I personally use .25mg E3D of adex on my testosterone replacement therapy (TRT). Any higher and my joints ache, any lower and I start to bloat/get itchy nipples/feel higher E sides.
 
I have been reading a good bit recently on people using sub q test inj for testosterone replacement therapy (TRT) and eliminating the need for Aromatase inhibitor (AI) use. i do not know that much about it but it may be worth looking into.
 
Doesn't test have to be injected intra-muscular?

No, it's just a more efficient method of delivery. SubQ shots are slower in absorption, which is why some guys like it that way. I've read the opposite with regards to aromatization as you're injecting into a fatty area which is where aromatase is present. But that's pushing the boundaries of "bro-science" as I've never tested it or seen any actual studies performed distinguishing between the two.
 
There was one study out of Canada a couple of years ago, let me see if I can find it.

Here it is :

STABLE TESTOSTERONE LEVELS ACHIEVED WITH SUBCUTANEOUS TESTOSTERONE INJECTIONS

M.B. Greenspan, C.M. Chang
Division of Urology, Department of Surgery, McMaster University,
Hamilton, ON, Canada

Objectives: The preferred technique of androgen replacement has been intramuscular (IM) testosterone, but wide variations in testosterone levels are often seen. Subcutaneous (SC) testosterone injection is a novel approach; however, its physiological effects are unclear. We therefore investigated the sustainability of stable testosterone levels using SC therapy. Patients and methods: Between May and September 2005, we conducted a small pilot study involving 10 male patients with symptomatic late-onset hypogonadism.

Every patient had been stable on TE 200 mg IM for 1 year. Patients were instructed to self-inject with testosterone enanthate (TE) 100 mg SC (DELATESTRYL 200 mg/cc, Theramed Corp, Canada) into the anterior abdomen once weekly. Some patients were down-titrated to 50 mg based on their total testosterone (T) at 4 weeks.

Informed consent was obtained as SC testosterone administration is not officially approved by Health Canada. T levels were measured before and 24 hours after injection during weeks 1, 2, 3, and 4, and 96 hours after injection in week 6 and 8.

At week 12, PSA, CBC, and T levels were measured however; the week 12 data are still being collected.

Results: Prior to initiation of SC therapy, T was 19.14+3.48 nmol/l, hemoglobin 15.8+1.3 g/dl, hematocrit 0.47+0.02, and PSA 1.05+0.65 ng/ml. During the first 4 weeks, there was a steady increase in pre-injection T from 19.14+3.48 to 23.89+9.15 nmol/l (p¼0.1). However, after 8 weeks the post-injection T (25.77+7.67 nmol/l) remained similar to that of week 1 (27.46+12.91 nmol/l). Patients tolerated this therapy with no adverse effects.

Conclusions: A once-week SC injection of 50;100 mg of TE appears to achieve sustainable and stable levels of physiological T. This technique offers fewer physician visits and the use of smaller quantity of medication, thus lower costs. However, the long term clinical and physiological effects of this therapy need further evaluation.

http://www.steroidology.com/forum/anabolic-steroid-forum/615076-subcutaneous-testosterone-injections.html#post2947046
 
Last edited:
Back
Top